Tocilizumab has no direct effect on cell lines infected with human T-cell leukemia virus type 1

OBJECTIVE: It remains unclear whether human T-cell leukemia virus type 1 (HTLV-1) infection influences therapeutic responses in patients with rheumatic diseases and whether immunosuppressive treatments increase the risk of HTLV-1-related complications in HTLV-1 carriers with rheumatic diseases. We e...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Yushiro, Fukui, Shoichi, Koga, Tomohiro, Sasaki, Daisuke, Hasegawa, Hiroo, Yanagihara, Katsunori, Okayama, Akihiko, Nakamura, Tatsufumi, Kawakami, Atsushi, Nakamura, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Pre-Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989142/
https://www.ncbi.nlm.nih.gov/pubmed/33745335
http://dx.doi.org/10.1177/03000605211002083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7989142/
https://www.ncbi.nlm.nih.gov/pubmed/33745335
http://dx.doi.org/10.1177/03000605211002083

Ejemplares similares